The clinical hallmark of HI is diffuse hyperkeratosis
skin and loss of the barrier that serves as the skin's defense mechanism. HI is
a dangerous, uncommon, and occasionally fatal skin condition with a wide range
of consequences. Normal skin cornification starts between 14 and 16 weeks of
pregnancy. The skin lesions can be detected as early as the second trimester of
pregnancy, opening the door to a 2D ultrasound-based prenatal diagnosis of HI.
Normal fetal facial lesions can now be seen in ultrasound exams, particularly
three-dimensional ultrasonography, which is more intuitive and vivid than
before [10-14]. Infants with HI have a high mortality rate, a dismal prognosis,
and the majority pass away very soon after birth from infection, heat loss,
dehydration, electrolyte imbalances, or respiratory distress. Prenatal
diagnosis is crucial since there is a 25% chance that a pregnancy will return
[7].
Fetoscopy with skin biopsy and ultrastructural
analysis of the cells in the amniotic fluid and hair canal may be beneficial in
patients with family histories [12]. Many cases are overlooked by people
without a family history. By combining this case with earlier literature
reports the ultrasonic characteristics of HI were examined in this study
[15-19]. They include the following: (1 the presence of ectropion; (2) the
presence of an abnormal double auricle; (3) the presence of thickened skin that
appears to be armor;( 4) the presence of double lips thickened valgus, a
sustained state of an open mouth that resembles a fish's mouth; (5) the
presence of limb contracture.
We investigated the reasons and found that in the
typical fetus, keratinization does not start until 22 to 24 weeks of gestation
[16,17]. A chorionic villus or amniotic fluid sample may be used to confirm the
diagnosis when the ABCA12 mutation has been identified (6), although the target
gene is not commonly investigated in patients without a family history.
The majority of ultrasound's distinguishing
characteristics won't be seen until much later in pregnancy; when the fetus's
growth and movements are constrained by restricted skin development. A prenatal
diagnosis is commonly missed during this gestational stage since it is
challenging to do a systematic fetal examination due to the pregnant woman's
conceptual difficulties and some fetuses are not examined during the third
trimester although the morphological scan at 20 weeks of gestation was
unremarkable, 19 observed an HI fetus. However, by 26 weeks 15, aberrant facial
traits, incurved toes, clenched fists, and polyhydramnios were visible. In
order to detect any HI symptoms or other structural abnormalities, it is
required to perform a series of ultrasound scans for high-risk pregnant women
in the middle and late stages of the pregnancy.
A single ultrasound test cannot entirely rule out HI
as a possible diagnosis. Prenatal diagnosis in low-risk pregnancies is
extremely challenging without any indication of HI, nevertheless. Most cases
that have been recorded have a late-pregnancy diagnosis.
Unfortunately, due to the effects of gestational age,
fetal position, and maternal obesity, fetal face, and limb morphologic
abnormalities may not be totally exposed, which will cause low-risk cases to be
ignored. For the prenatal diagnosis of HI, specific information regarding the
family history and past affected children is crucial. In our instance, HI was
detected at the end of the second trimester but was not more obvious in the
first [4,5,6,11].
The ABCA12 gene pathogenic mutation causes
hyperkeratosis and impaired barrier function. ARCI, encompassing HI, congenital
ichthyosiform erythroderma, and lamellar ichthyosis, has been linked to
mutations in ABCA12. The most severe phenotype is seen in HI. The ABCA12
mutations are connected to almost all HI cases Since nonsense and frameshift
substitutions are likely to result in a shortened protein and a significant
loss of ABCA12 function, the majority of pathogenic mutations connected to HI
are homozygous or compound heterozygous, as was previously observed. However,
there is debate concerning the genotype/phenotype relationship of HI with
ABCA12 mutations [20].
In contrast to all deaths, which were linked to
homozygous mutations [21,22]. Reported that 52% of HI survivors had compound
heterozygous mutations in the ABCA12 gene. The most severe and lethal form of
HI occurred in those who were homozygous for a harmful loss-of-function allele.
Compound heterozygous individuals had less severe symptoms. The clinical
prognosis of HI correlates only with the residual protein function, not with
homozygosity or compound heterozygosity; and that a less severe ARCI is typically
caused by the presence of a residual protein function. The severity of HI, on
the other hand, is likewise linked to the ABCA12 mutant protein's differential
expression.
A case of HI with variable expression of alternatively
spliced mutant ABCA12 transcripts that had a good prognosis was described [21].
This couple must both complete karyotypes for our
case. Preimplantation genetic diagnosis and in vitro fertilization are the
greatest options for the upcoming pregnancy.
A systematic examination during the third trimester of
pregnancy should be done in accordance with the clinical characteristics of the
disease to avoid missing a diagnosis of HI, especially in cases without a
family history.
In conclusion, HI can be easily detected by 2D
ultrasound combined with 3D ultrasound. Most often, the fetus dies while the
mother is pregnant, eliminating the chance of a live birth. Numerous
HI-affected fetuses have been born alive, despite having significant
respiratory problems or feeding issues. Therefore, there is a substantial
likelihood that new-borns with HI may die from respiratory failure, fluid loss,
or skin infection [14].
For proper perinatal and postnatal care as well as to
prepare parents for future pregnancies, fetal HI must be diagnosed during
pregnancy [23-25].